Synageva BioPharma (GEVA)

[surf1944]

Trimeris Reports First Quarter 2008 FUZEON(R) Sales Results
Trimeris, Inc. (Nasdaq: TRMS) today announced worldwide net sales of FUZEON for the first quarter of 2008 were $42.7 million, down 34 percent from $64.3 million in the first quarter of 2007. Net sales of FUZEON in the U.S. and Canada for the first quarter of 2008 were $17.0 million, down 42 percent from $29.3 million in the first quarter of 2007. Net sales of FUZEON outside the U.S. and Canada for the first quarter of 2008 were $25.7 million, down 26 percent from $35.0 million in the first quarter of 2007. All sales of FUZEON are recorded by F. Hoffmann-La Roche Ltd, ("Roche"), Trimeris' collaborative partner.

The release of complete financial results for the first quarter of 2008 will take place in early May 2008.

Net Fuzeon Sales

The table below presents net FUZEON sales by quarter beginning in the first quarter of 2006:

(millions)

2008
Q1 Q2 Q3 Q4 Total
U.S/Canada Net Sales $ 17.0 - - - $ 17.0
Ex. U.S/Canada Net Sales 25.7 - - - 25.7
Global Net Sales $ 42.7 - - - $ 42.7
Brazil Purchase - - - - -

2007
Q1 Q2 Q3 Q4 Total
U.S/Canada Net Sales $ 29.3 $ 32.9 $ 30.6 $ 31.5 $ 124.3
Ex. U.S/Canada Net Sales 35.0 29.2 43.3 35.0 142.5
Global Net Sales $ 64.3 $ 62.0 $ 73.9 $ 66.5 $ 266.8
Brazil Purchase $ 6.0 - $ 13.8 $ 7.3 $ 27.1


2006
Q1 Q2 Q3 Q4 Total
U.S/Canada Net Sales $ 27.4 $ 31.1 $ 33.5 $ 42.2 $ 134.2
Ex. U.S/Canada Net Sales 28.0 26.2 29.5 31.1 114.8
Global Net Sales $ 55.4 $ 57.2 $ 63.0 $ 73.3 $ 249.0
Brazil Purchase $ 5.3 - $ 4.4 $ 4.7 $ 14.3

(numbers may not add due to rounding)


About Trimeris, Inc.